Page last updated: 2024-10-22

antipyrine and Muscular Atrophy, Spinal

antipyrine has been researched along with Muscular Atrophy, Spinal in 1 studies

Antipyrine: An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29)
antipyrine : A pyrazolone derivative that is 1,2-dihydropyrazol-3-one substituted with methyl groups at N-1 and C-5 and with a phenyl group at N-2.

Muscular Atrophy, Spinal: A group of disorders marked by progressive degeneration of motor neurons in the spinal cord resulting in weakness and muscular atrophy, usually without evidence of injury to the corticospinal tracts. Diseases in this category include Werdnig-Hoffmann disease and later onset SPINAL MUSCULAR ATROPHIES OF CHILDHOOD, most of which are hereditary. (Adams et al., Principles of Neurology, 6th ed, p1089)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ando, S1
Funato, M1
Ohuchi, K1
Kameyama, T1
Inagaki, S1
Seki, J1
Kawase, C1
Tsuruma, K1
Shimazawa, M1
Kaneko, H1
Hara, H1

Other Studies

1 other study available for antipyrine and Muscular Atrophy, Spinal

ArticleYear
Edaravone is a candidate agent for spinal muscular atrophy: In vitro analysis using a human induced pluripotent stem cells-derived disease model.
    European journal of pharmacology, 2017, Nov-05, Volume: 814

    Topics: Animals; Antipyrine; Apoptosis; Disease Models, Animal; Edaravone; Fibroblasts; Humans; Induced Plur

2017